Patents by Inventor François LEMARE

François LEMARE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral suspension of temozolomide
    Patent number: 11730732
    Abstract: A pharmaceutical liquid suspension comprising: temozolomide or a salt thereof; at least one agent controlling the solid state of temozolomide in suspension; a pharmaceutically acceptable liquid vehicle; and optionally at least one acid in a quantity so that the pH of the composition is below 5; or a powder blend for reconstituting said suspension, is provided.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: August 22, 2023
    Assignees: Orphelia Pharma, Institut Gustave Roussy
    Inventors: Maxime Annereau, Jérémy Bastid, Hugues Bienayme, François Lemare, Mathieu Schmitt, Lionel Tortolano, Samuel Abbou
  • ORAL SUSPENSION OF TEMOZOLOMIDE
    Publication number: 20200188390
    Abstract: The present invention concerns a pharmaceutical composition, advantageously a liquid suspension, comprising: a. temozolomide or a salt thereof; b. at least one agent controlling the solid state of temozolomide in suspension; c. a pharmaceutically acceptable liquid vehicle, advantageously water; d. optionally at least one acid in a quantity so that the pH of the composition is below 5; or a powder blend for reconstituting said suspension.
    Type: Application
    Filed: December 13, 2019
    Publication date: June 18, 2020
    Applicants: Orphelia Pharma, Institut Gustave Roussy
    Inventors: Maxime ANNEREAU, Jérémy BASTID, Hugues BIENAYME, François LEMARE, Mathieu SCHMITT, Lionel TORTOLANO